Evidence map›Paper›PMID 39638416›Full record

GuidelineThe European respiratory journal2025

GOLD Science Committee recommendations for the use of pre- and post-bronchodilator spirometry for the diagnosis of COPD.

Dave Singh, Robert Stockley, Antonio Anzueto, Alvar Agusti, Jean Bourbeau, Bartolome R Celli, Gerard J Criner, MeiLan K Han, Fernando J Martinez, Maria Montes de Oca and 11 more

Abstract readPractice GuidelineReview
In one paragraph

Guideline in The European respiratory journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Dave SinghUniversity of Manchester, Manchester University NHS Foundation Hospital Trust, Manchester, UK dsingh@meu.org.uk.
Robert StockleyUniversity Hospital, Birmingham, UK.
Antonio AnzuetoSouth Texas Veterans Health Care System, University of Texas, San Antonio, TX, USA.
Alvar AgustiRespiratory Institute, Hospital Clinic, IDIBAPS, University of Barcelona and CIBERES Barcelona, Barcelona, Spain.ORCID https://orcid.org/0000-0003-3271-3788
Jean BourbeauMcGill University Health Centre, McGill University, Montreal, QC, Canada.ORCID https://orcid.org/0000-0002-7649-038X
Bartolome R CelliHarvard Medical School, Boston, MA, USA.ORCID https://orcid.org/0000-0002-7266-8371
Gerard J CrinerLewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
MeiLan K HanUniversity of Michigan, Ann Arbor, MI, USA.
Fernando J MartinezWeill Cornell Medical Center/New York-Presbyterian Hospital, New York, NY, USA.
Maria Montes de OcaHospital Universitario de Caracas, Universidad Central de Venezuela, Centro Médico de Caracas, Caracas, Venezuela.
Obianuju B OzohCollege of Medicine, University of Lagos, Lagos, Nigeria.
Alberto PapiRespiratory Medicine, University of Ferrara, Ferrara, Italy.ORCID https://orcid.org/0000-0002-6924-4500
Ian PavordRespiratory Medicine Unit and Oxford Respiratory NIHR Biomedical Research Centre, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Nicolas RochePneumologie, Hôpital Cochin AP-HP.Centre, Université Paris Cité, UMR 1016, Institut Cochin, Paris, France.ORCID https://orcid.org/0000-0002-3162-5033
Sandeep SalviPulmocare Research and Education (PURE) Foundation, Pune, India.
Don D SinCentre for Heart Lung Innovation, St Paul's Hospital and University of British Columbia Division of Respiratory Medicine, Vancouver, BC, Canada.
Thierry TroostersDepartment of Rehabilitation Sciences and Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), KU Leuven, Leuven, Belgium.
Jadwiga WedzichaNational Heart and Lung Institute, Imperial College London, London, UK.
Jinping ZhengNational Clinical Research Center of Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.ORCID https://orcid.org/0000-0002-7511-661X
Claus VolgelmeierDepartment of Medicine, Pulmonary and Critical Care Medicine, University Hospital Giessen and Marburg, German Center for Lung Research (DZL), University of Marburg, Marburg, Germany.
David HalpinUniversity of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter, UK.ORCID https://orcid.org/0000-0003-2009-4406

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) report states that the diagnosis of COPD should be considered in individuals with chronic respiratory symptoms and/or exposure to risk factors. Forced spirometry demonstrating airflow obstruction after bronchodilation is required to confirm the diagnosis using a threshold of forced expiratory volume in 1 s (FEV

Indexed as

Bronchodilator AgentsPulmonary Disease, Chronic ObstructiveSpirometryForced Expiratory VolumeHumansVital CapacityBronchodilator Agents

Identifiers

PMID39638416
PMCPMC11799884

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.